PMC:7652766 / 98203-98544 JSONTXT

{"project":"LitCovid-sentences","denotations":[{"id":"T479","span":{"begin":0,"end":341},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Hung et al. (322) assessed the effect of IFN-β on COVID-19 patients and found that the triple combination of IFN-β1b, lopinavir/ritonavir, and ribavirin was safer and more effective than lopinavir/ritonavir alone at alleviating symptoms, shortening the duration of viral shedding and hospital stay in patients with mild to moderate COVID-19."}

{"project":"LitCovid-PubTator","denotations":[{"id":"3617","span":{"begin":41,"end":46},"obj":"Gene"},{"id":"3618","span":{"begin":59,"end":67},"obj":"Species"},{"id":"3619","span":{"begin":301,"end":309},"obj":"Species"},{"id":"3626","span":{"begin":118,"end":137},"obj":"Chemical"},{"id":"3627","span":{"begin":143,"end":152},"obj":"Chemical"},{"id":"3628","span":{"begin":187,"end":206},"obj":"Chemical"},{"id":"3632","span":{"begin":50,"end":58},"obj":"Disease"},{"id":"3633","span":{"begin":332,"end":340},"obj":"Disease"}],"attributes":[{"id":"A3617","pred":"tao:has_database_id","subj":"3617","obj":"Gene:3439"},{"id":"A3618","pred":"tao:has_database_id","subj":"3618","obj":"Tax:9606"},{"id":"A3619","pred":"tao:has_database_id","subj":"3619","obj":"Tax:9606"},{"id":"A3626","pred":"tao:has_database_id","subj":"3626","obj":"MESH:C558899"},{"id":"A3627","pred":"tao:has_database_id","subj":"3627","obj":"MESH:D012254"},{"id":"A3628","pred":"tao:has_database_id","subj":"3628","obj":"MESH:C558899"},{"id":"A3632","pred":"tao:has_database_id","subj":"3632","obj":"MESH:C000657245"},{"id":"A3633","pred":"tao:has_database_id","subj":"3633","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Hung et al. (322) assessed the effect of IFN-β on COVID-19 patients and found that the triple combination of IFN-β1b, lopinavir/ritonavir, and ribavirin was safer and more effective than lopinavir/ritonavir alone at alleviating symptoms, shortening the duration of viral shedding and hospital stay in patients with mild to moderate COVID-19."}